Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-10-13

Clinical Trial Update: Ulinastatin Treatment in Adult Patients With Sepsis and Septic Shock in China [Phase 4]

View source ↗

Summary

Phase 4 trial update on ulinastatin for adults with sepsis and septic shock conducted in China.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ulinastatin (ulinastatin)

Snippet

Sponsor: Peking Union Medical College Hospital | Conditions: Sepsis, Septic Shock | Phase 4 | Status: COMPLETED